183 related articles for article (PubMed ID: 28427387)
1. Serum MicroRNA profile in patients with colon adenomas or cancer.
Zhang Y; Li M; Ding Y; Fan Z; Zhang J; Zhang H; Jiang B; Zhu Y
BMC Med Genomics; 2017 Apr; 10(1):23. PubMed ID: 28427387
[TBL] [Abstract][Full Text] [Related]
2. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway.
Sabry D; El-Deek SEM; Maher M; El-Baz MAH; El-Bader HM; Amer E; Hassan EA; Fathy W; El-Deek HEM
Mol Cell Biochem; 2019 Apr; 454(1-2):177-189. PubMed ID: 30357530
[TBL] [Abstract][Full Text] [Related]
3. Circulating exosomal microRNAs as biomarkers of colon cancer.
Ogata-Kawata H; Izumiya M; Kurioka D; Honma Y; Yamada Y; Furuta K; Gunji T; Ohta H; Okamoto H; Sonoda H; Watanabe M; Nakagama H; Yokota J; Kohno T; Tsuchiya N
PLoS One; 2014; 9(4):e92921. PubMed ID: 24705249
[TBL] [Abstract][Full Text] [Related]
4. Novel circulating microRNAs expression profile in colon cancer: a pilot study.
Wang YN; Chen ZH; Chen WC
Eur J Med Res; 2017 Nov; 22(1):51. PubMed ID: 29187262
[TBL] [Abstract][Full Text] [Related]
5. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
6. Rare circulating microRNAs as biomarkers of colorectal neoplasia.
Adams SV; Newcomb PA; Burnett-Hartman AN; Wurscher MA; Mandelson M; Upton MP; Zhu LC; Potter JD; Makar KW
PLoS One; 2014; 9(10):e108668. PubMed ID: 25286412
[TBL] [Abstract][Full Text] [Related]
7. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.
Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S
Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Potential of Cell-Free and Exosomal MicroRNAs in the Identification of Patients with High-Risk Colorectal Adenomas.
Uratani R; Toiyama Y; Kitajima T; Kawamura M; Hiro J; Kobayashi M; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Goel A; Kusunoki M
PLoS One; 2016; 11(10):e0160722. PubMed ID: 27760147
[TBL] [Abstract][Full Text] [Related]
9. miRNA expression in colon polyps provides evidence for a multihit model of colon cancer.
Oberg AL; French AJ; Sarver AL; Subramanian S; Morlan BW; Riska SM; Borralho PM; Cunningham JM; Boardman LA; Wang L; Smyrk TC; Asmann Y; Steer CJ; Thibodeau SN
PLoS One; 2011; 6(6):e20465. PubMed ID: 21694772
[TBL] [Abstract][Full Text] [Related]
10. Fecal MicroRNAs as novel biomarkers for colon cancer screening.
Link A; Balaguer F; Shen Y; Nagasaka T; Lozano JJ; Boland CR; Goel A
Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1766-74. PubMed ID: 20551304
[TBL] [Abstract][Full Text] [Related]
11. Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progression.
Aherne ST; Madden SF; Hughes DJ; Pardini B; Naccarati A; Levy M; Vodicka P; Neary P; Dowling P; Clynes M
BMC Cancer; 2015 Apr; 15():329. PubMed ID: 25924769
[TBL] [Abstract][Full Text] [Related]
12. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
[TBL] [Abstract][Full Text] [Related]
13. Small RNA sequencing of sessile serrated polyps identifies microRNA profile associated with colon cancer.
Kanth P; Hazel MW; Boucher KM; Yang Z; Wang L; Bronner MP; Boylan KE; Burt RW; Westover M; Neklason DW; Delker DA
Genes Chromosomes Cancer; 2019 Jan; 58(1):23-33. PubMed ID: 30265426
[TBL] [Abstract][Full Text] [Related]
14. Modeling microRNA-mRNA interactions using PLS regression in human colon cancer.
Li X; Gill R; Cooper NG; Yoo JK; Datta S
BMC Med Genomics; 2011 May; 4():44. PubMed ID: 21595958
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the expression level of miR-9-5p and miR-192-5p in gastrointestinal cancer: introducing novel screening biomarkers for patients.
Tavakolian S; Goudarzi H; Faghihloo E
BMC Res Notes; 2020 Apr; 13(1):226. PubMed ID: 32307002
[TBL] [Abstract][Full Text] [Related]
16. Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer.
Wang J; Yan F; Zhao Q; Zhan F; Wang R; Wang L; Zhang Y; Huang X
Sci Rep; 2017 Jun; 7(1):4150. PubMed ID: 28646161
[TBL] [Abstract][Full Text] [Related]
17. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
[TBL] [Abstract][Full Text] [Related]
18. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
19. Identification of Molecular Targets for Predicting Colon Adenocarcinoma.
Wang Y; Zhang J; Li L; Xu X; Zhang Y; Teng Z; Wu F
Med Sci Monit; 2016 Feb; 22():460-8. PubMed ID: 26868022
[TBL] [Abstract][Full Text] [Related]
20. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
